Braxia Scientific Appoints Dr. David Greenberg to Board of Directors

TORONTO, May 31, 2021 /PRNewswire/ – Braxia Scientific Corp. (the “Company”), (CSE: BRAX) (OTC: BRAXF) (FWB: 496), a analysis pushed scientific platform creating and offering modern ketamine remedies for individuals with despair and associated problems, is happy to announce it has appointed Dr. David Greenberg to its Board of Directors.
A nationally acknowledged common medical practitioner for greater than 30 years and a lecturer at The University of Toronto within the Department of Family and Community Medicine, Dr. David Greenberg brings intensive expertise in Mental Health and Concussions.  He has developed and applied a number of teaching programs for medical practitioners, nationally and internationally, and is considered a world well being skilled and keynote speaker on the subject of despair and associated problems.
Dr. Greenberg is the Team Physician for the Toronto Argonauts, of the Canadian Football League, and is an skilled panel member for the ECHO Concussion Program (ECHO) on the University Health Network. The ECHO Concussion program is an interactive medical schooling program, connecting well being care suppliers with an interprofessional specialist group to advance studying and improve scientific abilities. There are greater than 330 ECHO hubs in 37 international locations, together with USA, UK and Australia and is acknowledged internationally for its modern analysis and greatest practices within the space of concussion and associated situations. Dr. Greenberg can also be a member of The Center for Effective Practice, a working group that broadly is fascinated by bettering greatest practices and implementation of care in main look after concussions.  
“We are thrilled to welcome Dr. Greenberg to the Board as we set up Braxia because the chief in setting the usual of care in psychological well being for despair and as we develop our scientific platform to assist improvement of novel ketamine and psychedelic primarily based medicines in Canada and the United States,” stated Dr. Roger McIntyre, CEO, Braxia Scientific. “Dr. Greenberg’s intensive expertise and community throughout the North American and worldwide healthcare neighborhood, particularly within the areas of psychological well being and concussion and with skilled athletes, amongst others, will probably be a major benefit as we proceed to develop and implement breakthrough Ketamine remedies and protocols that may end in improved outcomes for sufferers that come to our clinics.”
Dr. Greenberg consults for numerous firms on Sales, Marketing, Communications, and Business Development methods. He was beforehand President of Goldfarb Health Care, which was Canada’s largest market analysis firm throughout his tenure.  He has continued working with Health Care associated firms through the years, offering skilled recommendation and insights into the beliefs, values and behaviours of each customers and physicians to develop extremely efficient instructional packages, public relations, and gross sales and advertising methods. Dr. Greenberg serves as a Mentor on the Creative Destruction Lab on the Rotman Business School at The University of Toronto and the Said Business School at Oxford University. Through this incubator program, he mentors founders pursuing industrial alternatives predicated on translational science and expertise improvements that enhance human well being and wellness.
Dr. Greenberg is a member of the ProSpeakers Bureau, a company that may be a trusted and dependable useful resource for famend keynote audio system, and continues to be a company spokesperson for numerous organizations.
Dr. Greenberg developed a nationwide popularity for successfully conveying extremely complicated points and ideas in an easy and entertaining method.  He was the resident General Practitioner on “The Mom Show” (5 seasons), CityLine (9 Seasons) and the host of his personal present “Dr. in The House” (2 seasons), in addition to many different media appearances as “Dr. Dave”.
Stock Option Grant
The Company additionally introduced it has granted inventory choices to sure of its administrators, officers, staff and consultants to purchase an mixture of 9,750,000 widespread shares of the Company. Each possibility is exercisable into one widespread share of the Company at an train worth of $0.395 per Share, being the closing buying and selling worth of the shares on the Canadian Securities Exchange on May 28, 2021, for a five-year time period expiring on May 28, 2026. Subject to sure accelerated vesting provisions, one-third of the choices will vest instantly, one-third will vest after 12 months, and the remaining one-third will vest 18 months after the date of the grant.
Media Services Engagement
The Company is happy to announce it has engaged the providers of Stock Day Media to present media providers. Under the phrases of the settlement, Stock Day Media will characteristic the Company on its podcasts and supply a mix of information distribution and marketing campaign reporting at a complete price of $12,000 USD over an anticipated three-month interval, topic to renewal.
About Braxia Scientific Corp.
Braxia Scientific is a analysis pushed medical options firm that goals to scale back the sickness burden of brain-based psychological problems akin to main depressive dysfunction amongst others. Braxia Scientific is primarily centered on (i) proudly owning and working multidisciplinary clinics offering remedy for psychological well being problems and (ii) analysis actions associated to discovering and commercializing novel medication and supply strategies. The Company develops ketamine and psilocybin derivatives and different psychedelic merchandise from its IP improvement platform. Braxia Scientific, via its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., at the moment operates multidisciplinary community-based clinics providing rapid-onset remedies for despair situated in Mississauga, Toronto, Ottawa, and Montreal.
“Dr. Roger S. McIntyre”Dr. Roger S. McIntyreChairman & CEO
The CSE has not reviewed and doesn’t settle for duty for the accuracy or adequacy of this launch.
Forward-looking Information Cautionary StatementThis information launch accommodates forward-looking statements throughout the that means of relevant securities legal guidelines. All statements that aren’t historic details, future estimates, plans, packages, forecasts, projections, targets, assumptions, expectations, or beliefs of future efficiency are “forward-looking statements.” Forward-looking statements embody statements concerning the supposed promise of ketamine and esketamine-based remedies for despair, and the potential for ketamine to deal with different rising psychiatric problems, for the Company to be a frontrunner on this house and for the Company’s capacity to develop its scientific community. Such forward- wanting statements contain identified and unknown dangers, uncertainties and different components which will trigger precise outcomes, occasions, or developments to be materially completely different from any future outcomes, occasions or developments expressed or implied by such forward-looking statements. Such dangers and uncertainties embody, amongst others, the failure of ketamine to present the anticipated well being advantages and unanticipated unintended effects, dependence on acquiring and sustaining regulatory approvals, together with buying and renewing federal, provincial, municipal, native or different licenses and interesting in actions that may very well be later decided to be unlawful underneath home or worldwide legal guidelines. These components must be thought-about rigorously, and readers are cautioned not to place undue reliance on such forward-looking statements. Although the Company has tried to establish vital danger components that would trigger precise actions, occasions or outcomes to differ materially from these described in forward-looking statements, there could also be different danger components that trigger actions, occasions or outcomes to differ from these anticipated, estimated or supposed. Additional data figuring out dangers and uncertainties that would have an effect on monetary outcomes is contained within the Company’s filings with Canadian securities regulators, together with the Amended and Restated Listing Statement dated April 15, 2021, which can be found at There will be no assurance that forward-looking statements will show to be correct, as precise outcomes and future occasions might differ materially from these anticipated in forward-looking statements.
SOURCE Braxia Scientific Corp.
Related Links

Recommended For You